PMC:7795856 / 6712-6965 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"172","span":{"begin":85,"end":88},"obj":"Gene"},{"id":"173","span":{"begin":233,"end":240},"obj":"Species"}],"attributes":[{"id":"A172","pred":"tao:has_database_id","subj":"172","obj":"Gene:134864"},{"id":"A173","pred":"tao:has_database_id","subj":"173","obj":"Tax:562"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"® technology in order to overcome both of these obstacles of the currently available Tα1 drug and to create a long-lasting N-terminally acetylated therapeutic peptide, also offering cheap and efficient biotechnological production in E. coli. To this end"}